227
Views
39
CrossRef citations to date
0
Altmetric
Articles

Sonochemical degradation of twenty-three emerging contaminants in urban wastewater

, , &
Pages 6601-6608 | Received 09 Jan 2012, Accepted 14 Jan 2013, Published online: 06 Mar 2013
 

Abstract

The occurrence and fate of pharmaceuticals in the environment, and in aquatic media in particular, have received considerable attention by the scientific community during the last two decades. Pharmaceuticals, which are designed to be biologically active substances, are usually lipophilic and resistant to biodegradation, thus having the potential for accumulation and persistence in the environment. Although they are usually present at relatively low concentrations, ranging between ng/L and μg/L levels, they may cause serious effects on the environment. In this study, the removal efficiency of sonolysis has been tested on a mixture of 23 pharmaceuticals. Diclofenac and carbamazepine degradations were tested at different power densities (100–400 W/L) using low frequency. These compounds were spiked separately in wastewater at high concentrations (mg/L). Subsequently, low-frequency ultrasound-induced degradation of a mixture of 23 emerging contaminants with low concentration (μg/L) in urban wastewater was investigated, working at 100 W/L. It was found that the pharmaceuticals conversion is enhanced at increased applied power densities. The reaction rate for different pharmaceuticals is almost the same in the mixtures and the kinetic regimes are mainly pseudo-first order.

Acknowledgments

This research is part of a research project funded by the University of Salerno (FARB). The authors acknowledge the Department of Civil and Environmental Engineering at the University of Washington (Seattle, WA, USA) for their great contribution to the experiments. Assistance provided by P. Napodano, Dr V. Nanaboina, Prof. G. Korshin, and Prof. M.M. Benjamin is deeply appreciated.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.